Cervical Malignancies and Potential Pap Pitfalls
Rachel Conrad, MD
Rosemary Zuna, MD
University of Oklahoma College of Medicine
Due to successful cervical screening programs, malignant Pap tests are decreasing in number in most laboratories. This leads to fewer opportunities for cytotechnologists and cytopathologists to view cervical malignancies on Pap tests and develop familiarity with cytomorphologic features of malignancy. As the recommended interval between Pap tests increases, prompt recognition of these features will become even more essential in providing quality patient care. This webinar reviews our experience with numerous Paps from confirmed cervical malignancies (squamous and glandular) with pertinent clinical, HPV, and histopathologic data. Key tips and challenging cases will also be discussed.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Develop expertise in the cytologic diagnosis of invasive cervical carcinomas by viewing Pap tests from women with cervical cancer
- Discuss cytomorphologic characteristics and potential pitfalls related to malignant Pap tests
- Review the current Bethesda guidelines for cervical malignancies on Pap tests
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant